Huang's team found that YTHDF2 is up‐regulated in intrahepatic cholangiocarcinoma (ICC) tissues, particularly in chemoresistant ICC, exhibiting oncogenic and cisplatin‐desensitising effects.221. The gene discussed is YTHDF2; the disease is intrahepatic cholangiocarcinoma.